Krsnaa Diagnostics board meet on Aug 13, 2026

What the company disclosed to exchanges

Krsnaa Diagnostics Limited (BSE: 543328; NSE: KRSNAA) has informed BSE and NSE that its Board of Directors will meet on Thursday, August 13, 2026. The disclosure was made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. According to the filing, the agenda includes approval of unaudited financial results for the quarter ended June 30, 2026. The board will also consider a proposal to raise funds through issuance of securities. The company said the matter, if taken forward, would be subject to required shareholder, regulatory, statutory, and other approvals.

Board meeting agenda: Q1 results for quarter ended June 30, 2026

The company stated that the board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This makes the August 13 meeting an important date for investors tracking Krsnaa’s quarterly performance. The filing does not provide any preliminary financial numbers for the quarter. It only specifies that the results are unaudited and will cover both standalone and consolidated accounts. The company has not indicated a time for the board meeting in the excerpt provided.

Fund-raising proposal under evaluation

Alongside results, the board will “consider and evaluate” a fund-raising proposal. As per the notice, the fund raising may be done by issuing one or more instruments or securities. The company listed possible instruments that may include equity shares, fully convertible warrants, and other eligible securities that could be convertible or non-convertible. It also mentioned that issuance could be done through permissible modes, including but not limited to a preferential issue. The filing indicates the company may need to conduct a shareholders’ meeting if required for approvals.

Trading window closure until August 15, 2026

Krsnaa Diagnostics also informed the exchanges that the trading window for dealing in the company’s securities will remain closed until August 15, 2026, with both days included. The closure is under the company’s Code of Conduct for Prevention of Insider Trading. Such closures typically coincide with the period around financial result preparation and approval. The disclosure provides a clear end date for the restriction in this case. The company also noted that the intimation would be uploaded on its website.

Stock and valuation snapshot cited in the available data

The available market snapshot shows Krsnaa Diagnostics trading around the Rs 560 level in early August 2026. One excerpt lists the share price as Rs 560.85. Another quote shows Rs 561.45, down Rs 0.70 (0.12%), with “Last Updated: Aug 5, 2026 4:35 p.m. IST (Delayed quote)”. A separate line mentions “Krsnaa Diagnostics share price is Rs 558.25 as on 05 Aug, 2026, 02:00 PM IST.” The same dataset cites a market capitalisation of about Rs 1,819.32291912 crore, calculated based on the latest share price referenced there. The day range shown in the snapshot is Rs 557.35 to Rs 566.95.

Company profile and operating context

Krsnaa Diagnostics is described as a diagnostics service provider in India with operations across urban and rural areas. The text lists its service offerings as pathology, radiology, imaging, and tele-radiology services. The company’s registered office address is shown in Pune, Maharashtra. Investor contact details include an email address (investors@krsnaa.in) and the company website (krsnaadiagnostics.com). The notice to exchanges is signed by Sujoy Sudipta Bose, Company Secretary and Compliance Officer.

Key details at a glance

Market impact: what investors typically track next

The immediate market relevance is tied to two scheduled outcomes: quarterly results approval and the board’s decision on whether to proceed with a fund-raising plan. If the company advances the issuance proposal, the next steps mentioned include obtaining shareholder and regulatory or statutory approvals, and potentially convening a shareholders’ meeting. Investors often monitor the type of instrument chosen and the issuance route because these can affect equity dilution and cost of capital, although the filing does not specify size, pricing, or timeline. For now, the only confirmed facts are that the proposal will be evaluated at the August 13 board meeting and that the trading window is closed until August 15.

Timeline of the disclosed event

Conclusion

Krsnaa Diagnostics has put two items on the agenda for its August 13, 2026 board meeting: approval of Q1 unaudited standalone and consolidated results, and evaluation of a potential fund raise through issuance of securities. The company has also extended the trading window closure until August 15, 2026. The next concrete update is expected after the board meeting, when the company finalises and discloses the quarterly results and any decision on fund raising, along with any approvals and process steps required thereafter.